The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Psychological support helps adolescents with chronic fatigue syndrome

Psychological support, in the form of cognitive behaviour therapy, is an effective treatment for adolescents with chronic fatigue syndrome, finds a new study published on bmj.com today.

Patients with chronic fatigue syndrome have debilitating unexplained severe fatigue that is not alleviated by rest. Trials have shown that cognitive behaviour therapy is effective in adults, but there have been no published studies on such therapy for adolescents.

Researchers in the Netherlands identified 71 adolescents aged 10-17 years with chronic fatigue syndrome; 36 were randomly assigned to immediate cognitive behaviour therapy and 35 to the waiting list for therapy.

The therapy comprised 10 individual sessions over five months. All participants were assessed after five months.

Patients in the therapy group reported significantly greater decrease in fatigue severity and functional impairment, while their attendance at school increased significantly. They also reported a significant reduction in other symptoms, such as impaired concentration, muscle pain, and headache.

"This study is the first randomised controlled trial to show that cognitive behaviour therapy can successfully be used to treat adolescents with chronic fatigue syndrome," conclude the authors.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
6-Dec-2004


Page: 1

Related medicine news :

1. Psychological factors may be root of back pain, say Stanford researchers
2. Psychological distress may predict hypertension
3. Dont think about it too much - Psychological healing in Angola
4. Psychologically abused women experience significant physical and mental health problems
5. Psychological attributes, not physical gifts, of young athletes predict success, say coaches in a new study
6. Airport Noise Can Seriously Affect The Health And Psychological Well-Being OfChildren
7. Americans support most uses of reproductive genetic testing, report on US attitudes reveals
8. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
9. Emergency department study supports giving dehydrated children fluids by mouth
10. Early supported discharge services can reduce long term dependency for stroke patients
11. Care of rural stroke patients improves with telephone support

Post Your Comments:
(Date:11/25/2009)... New minimally-invasive pro...inus pain and decrease the risk of sinusitis, or s...e physicians of the Atlanta Snoring Institute. Te...and congested sinuses without having to remove any... The advantages of these breakthroughs in treating...
(Date:11/25/2009)...,, VANCOUVER,Nov.25/PRNewswire/-- AdamDreamHeal...ealingintentionschangesthephysiologyofsomeoneatadi...atatimeunknowntoavolunteerwhowasmonitoredbyaquanti...AandCanada. ,, OnNovember8inVancouver,B.C.Adami...ent.Tofocusintentions,Adamcreatedavideoclipofaspec...
(Date:11/24/2009)... Eating high amounts of salt is linked to a signi... disease, states a paper published today in the B...ied out jointly by the World Health Organization,s...University of Warwick and University Hospital in C...ion Excellence Centre in Hypertension based at the...
(Date:11/24/2009)...(Boston) Researchers from Boston University Schoo...medical Engineering Department have identified a n...distinguish between cancer and normal cells with a...earchers have developed a new computational strate...key biological pathways (molecular circuits) that ...
(Date:11/24/2009)...,, DALLAS,Nov.24/PRNewswire-USNewswire/--TheBay...rofoneofthelargestcancerclinicaltrialscooperativeg...heNationalCancerInstitute,SouthwestOncologyGroupco...s,andtoimprovethequalityoflifeforcancersurvivors. ...eradditional,importantclinicaltrialstocancerpatien...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:High salt intake linked to strokes and cardiovascular disease 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--AnadysPharmaceutica...entatthe21stAnnualPiperJaffrayHealthcareConference....TheconferenceisbeingheldatTheNewYorkPalaceHotel.S...rofAnadys,willprovideanoverviewofAnadysanditsclini...orporatepresentationwillbesimultaneouslywebcastand...
(Date:11/24/2009)...ON,Calif.,Nov.24/PRNewswire-FirstCall/--ThoratecCo...dmechanicalcirculatorysupporttherapiestosave,suppo...ticipatinginthe21stAnnualPiperJaffrayHealthCareCon...cutivevicepresidentandchieffinancialofficer,willpr...ernStandardTime(5:30a.m.,PacificStandardTime). ,...
(Date:11/24/2009)...N.C.,Nov.24/PRNewswire/--PharmaceuticalInstitute,a...epharmaceuticalandbiotechindustry,todayannouncedth...Thenew HospitalMarketplace e-courseisthenewestaddi...ries,acomprehensiveseriesofe-coursesdesignedtofill...owledgeforcommercialprofessionals. ,, Thenewthr...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 1 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 3 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 4 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 5 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 6 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 7 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 8 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 9Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 1Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 3Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 4
Other News:
...similar to AIDS treatment. . Researchers have succ...hat -- in test tube studies -- can stop the chain ...ing reported in the current (April 12) print editi..., published by the American Chemical Society, the ...
.... . . . . People with sleep apnea are at special ... by the National Heart, Lung, and Blood Institute ...a from the NHLBI's "Sleep Heart Health Study" (SHH... of the Journal of the American Medical Associatio...
............ Columbia researchers have participated in a new study that points toward a potential treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.... The study, l
...spitals are contributing to health promotion and d...is significant variation in such efforts, accordin...elated hospitals and hospitals that are part of he...he largest percentages for offering services such ...
health news:Protease inhibitor could help prevent alzheimer's 2health news:NHLBI study shows relationship between sleep apnea and hypertension 2health news:Researchers identify pathway that may slow the progression of Lou Gehrig's disease 2health news:Hospitals vary in provision of wellness services 2
...updated the current guidelines for diagnosing mult...netic resonance imaging (MRI). The guidelines, pub...eurology (http://www.interscience.wiley.com/journa...ve years ago and named after the chair of the prev...
...te, they have more academic and attention problems...dical School to be published in the December issue...ensuring students get enough sleep is a significan...n class as well as minimizing behaviors characteri...
... eased the pain of millions of patients -- but it ...d stroke among some of them. And that extra risk o...of data from Vioxx research studies.......Failure ... go unnoticed but could frequently be prevented if...
People taking highly active antiretroviral therapy (HAART) for HIV infection remain susceptible to tuberculosis, though the risk is lower than for HIV-infected patients not on HAART, according to an a
health news:Neurologists refine multiple sclerosis diagnostic criteria 2health news:A good night's sleep can mean a better day at school 2health news:A good night's sleep can mean a better day at school 3health news:Preventing another Vioxx 2health news:Preventing another Vioxx 3health news:Preventing another Vioxx 4health news:Preventing another Vioxx 5health news:Tuberculosis still a risk for patients receiving HIV drugs 2